DENALI THERAPEUTICS INC
DNLI · NASDAQ
Updated at 2026-10-13 14:27:43
- Today's High
- $19.20
- Today’s Low
- $18.33
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $19.32
- Previous Close
- $18.95
- Volume
- 1.23M
- Market Cap
- $3.02B
- P/E Ratio
- --
- EPS
- $-2.83
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 161 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080
- Country
- US
- Listing Date
- 2017-12-08
- Fiscal Year End
- December
- Shares Outstanding
- 158.71M
- CIK
- 0001714899
- Website
- www.denalitherapeutics.com
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company is headquartered in South San Francisco, California.
Financial Metrics
Revenue
2026-06-30
$3.6M
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$134.05M
2026-03-31
$134.51M
2025-12-31
$134.49M
2025-09-30
$137.43M
Net Income
2026-06-30
-$127.55M
2026-03-31
-$128.44M
2025-12-31
-$128.54M
2025-09-30
-$126.9M
Net Profit Margin
2026-06-30
-3.53K%
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.68
2026-03-31
$-0.69
2025-12-31
$-0.73
2025-09-30
$-0.74
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$124.9M
2026-03-31
-$125.6M
2025-12-31
-$124.66M
2025-09-30
-$123.04M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
-0.07%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $3.6M | $0 | $0 | $0 |
| Operating Expenses | $134.05M | $134.51M | $134.49M | $137.43M |
| Net Income | -$127.55M | -$128.44M | -$128.54M | -$126.9M |
| Net Profit Margin | -3.53K% | -- | -- | -- |
| Earnings Per Share | $-0.68 | $-0.69 | $-0.73 | $-0.74 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$124.9M | -$125.6M | -$124.66M | -$123.04M |
| Effective Tax Rate | -- | -- | -0.07% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.